Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Other Non Operating Income (2020 - 2025)

Historic Other Non Operating Income for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to $47216.0.

  • iSpecimen's Other Non Operating Income fell 8262.07% to $47216.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $803251.0, marking a year-over-year increase of 11023.61%. This contributed to the annual value of $406181.0 for FY2024, which is 113871.98% up from last year.
  • According to the latest figures from Q3 2025, iSpecimen's Other Non Operating Income is $47216.0, which was down 8262.07% from $764165.0 recorded in Q2 2025.
  • iSpecimen's 5-year Other Non Operating Income high stood at $764165.0 for Q2 2025, and its period low was -$3.0 million during Q1 2021.
  • Moreover, its 5-year median value for Other Non Operating Income was $3148.0 (2022), whereas its average is -$113247.5.
  • Its Other Non Operating Income has fluctuated over the past 5 years, first tumbled by 54215.48% in 2023, then soared by 6195470.09% in 2024.
  • Over the past 5 years, iSpecimen's Other Non Operating Income (Quarter) stood at -$93950.0 in 2021, then surged by 103.35% to $3148.0 in 2022, then plummeted by 1050.79% to -$29931.0 in 2023, then soared by 80.55% to -$5821.0 in 2024, then skyrocketed by 911.13% to $47216.0 in 2025.
  • Its Other Non Operating Income stands at $47216.0 for Q3 2025, versus $764165.0 for Q2 2025 and -$2309.0 for Q1 2025.